Department of Nursing, Hebei College of Traditional Chinese Medicine, Shijiazhuang, China.
Department of Clinical Medicine, Qinghai University, Qinghai, China.
Medicine (Baltimore). 2022 Nov 11;101(45):e31662. doi: 10.1097/MD.0000000000031662.
Management of patients with chronic diseases in rural areas and the use of medications need to be urgently addressed. Therefore, this study aimed to evaluate the efficacy of a family-involved smart medication management system for rural patients with chronic diseases. Between June and August 2021, 82 patients with chronic diseases were selected using convenience sampling from 2 county towns in Hebei Province, China. They were randomly divided into control (41 participants) and experimental (41 participants) groups. The control group was managed using a routine medication management model for chronic diseases. The experimental group was managed using a family-involved smart medication management system, in addition to the control group interventions. The groups were graded using the 8-item Morisky Medication Adherence Scale (MMAS-8), the Self-efficacy for Appropriate Medication Use Scale (SEAMS), the Medication Knowledge Assessment Questionnaire, and the Family Support Scale before the intervention and at 8 and 24 weeks after the intervention. Pre-intervention group differences were not statistically significant. At 8 weeks after the intervention, the control group showed no statistically significant differences in the MMAS-8, SEAMS, and Medication Knowledge Assessment scores pre-and post-intervention. These scores were higher in the experimental group than in the control group, with the post-intervention scores being higher than the pre-intervention scores. The MMAS-8, SEAMS, and Medication Knowledge Assessment scores for the experimental group were higher at 24 weeks than at 8 weeks; these scores were higher in the experimental group than in the control group. The experimental group also had higher family support scores than the control group; these scores were higher pre-intervention than post-intervention. A family-involved smart medication management system can effectively improve medication adherence, self-efficacy for appropriate medication use, medication knowledge assessment scores, and family support for rural middle-aged and older adult patients with chronic diseases.
农村慢性病患者管理和用药问题亟待解决。因此，本研究旨在评估家庭参与式智能用药管理系统对农村慢性病患者的疗效。2021 年 6 月至 8 月，采用便利抽样法从河北省 2 个县城选取 82 例慢性病患者，随机分为对照组（41 例）和实验组（41 例）。对照组采用慢性病常规用药管理模式进行管理，实验组采用家庭参与式智能用药管理系统进行管理，同时采用对照组干预措施。在干预前和干预后 8 周和 24 周，采用 8 项 Morisky 用药依从性量表（MMAS-8）、适当用药自我效能量表（SEAMS）、用药知识评估问卷和家庭支持量表对两组进行评分。干预前两组差异无统计学意义。干预 8 周后，对照组 MMAS-8、SEAMS 和用药知识评估评分的组内比较差异无统计学意义，组间比较差异无统计学意义。实验组干预后 MMAS-8、SEAMS 和用药知识评估评分均高于对照组，且干预后评分高于干预前评分。实验组干预后 24 周 MMAS-8、SEAMS 和用药知识评估评分均高于干预后 8 周，实验组评分均高于对照组。实验组家庭支持评分也高于对照组，且干预前评分高于干预后评分。家庭参与式智能用药管理系统能有效提高农村中老年慢性病患者的用药依从性、适当用药自我效能、用药知识评估评分和家庭支持。
